<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04132622</url>
  </required_header>
  <id_info>
    <org_study_id>CYM2019</org_study_id>
    <nct_id>NCT04132622</nct_id>
  </id_info>
  <brief_title>Low Dose Euthyrox in Treatments of Paraquat Intoxication.</brief_title>
  <acronym>LDETPI</acronym>
  <official_title>Low Dose Euthyrox in Treatments of Paraquat Intoxication: a Randomized, Controlled, Multicenter Trial in China.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First People's Hospital of Hangzhou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang Provincial Hospital of TCM</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Paraquat is a common human toxicant and accounts for 20 deaths per million persons in the
      world. Paraquat usually cause multiple organ dysfunction syndrome, including liver, kidney,
      lung and heart dysfunction. Besides, pituitary insufficiency also occurs on those patients
      with paraquat poisoning, which leads to multiple endocrine gland dysfunction, involving
      adrenal gland, thyroid and sex gland.

      As a result, the investigators decide to initiate the clinical trial to find whether thyroid
      replacement therapy can furtherly reduce the mortality, and improve patients long-term
      prognosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Paraquat is a common human toxicant and accounts for 20 deaths per million persons in the
      world. Its accidental or deliberate ingestion is associated with a high mortality rate
      ranging from 40% to 70%. Paraquat usually cause multiple organ dysfunction syndrome,
      including liver, kidney, lung and heart dysfunction. Besides, pituitary insufficiency also
      occurs on those patients with paraquat poisoning, which leads to multiple endocrine gland
      dysfunction, involving adrenal gland, thyroid and sex gland. Nowadays, steroids, as a hormone
      replacement therapy, is one of most important drugs for paraquat poisoning, and it has
      decreased patients' mortality greatly since using it. However, the clinicians have not paid
      enough attention to thyroid replacement therapy, as thyroid dysfunction is also the key
      pathophysiological course when paraquat poisoning occurs.

      As a result, the investigators decide to initiate the clinical trial to find whether thyroid
      replacement therapy can furtherly reduce the mortality, and improve patients long-term
      prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of death weekly</measure>
    <time_frame>a week</time_frame>
    <description>Rate of death in a week.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of death monthly</measure>
    <time_frame>a month</time_frame>
    <description>Rate of death in a month.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of death yearly</measure>
    <time_frame>a year</time_frame>
    <description>Rate of death in a year.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Survival rate yearly</measure>
    <time_frame>a year</time_frame>
    <description>Survival rate in a year.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Kidney dysfunction</measure>
    <time_frame>a week, a month, a year</time_frame>
    <description>Number of Participants with Kidney dysfunction with paraquat poisoning</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Paraquat Poisoning</condition>
  <arm_group>
    <arm_group_label>Experimental therapy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Besides Traditional therapy，patients in this group will also receive thyroid replacement therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional therapy group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients in Standard therapy group will receive treatments according to guideline worldwide.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levothyroxine Sodium</intervention_name>
    <description>Levothyroxine Sodium Tablets (50 ug, calculated by Levothyroxine Sodium ), produced by Merck KGaA, Darmstadt.</description>
    <arm_group_label>Experimental therapy group</arm_group_label>
    <other_name>Euthyrox, H20140052</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Traditional therapy</intervention_name>
    <description>including steroids, vitamin C, hemodialysis and blood perfusion.</description>
    <arm_group_label>Experimental therapy group</arm_group_label>
    <arm_group_label>Traditional therapy group</arm_group_label>
    <other_name>Standard treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all the patients who are diagnosed by paraquat poisoning

        Exclusion Criteria:

          -  patients who can not cooperate with the trial; patients who would not like to join in
             the trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuemei Chen, doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital of Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuemei Chen, doctor</last_name>
    <phone>+86 18758120192</phone>
    <email>324347@zju.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiu Yang, master</last_name>
    <phone>+86 13732221703</phone>
  </overall_contact_backup>
  <reference>
    <citation>Hwang KY, Lee EY, Hong SY. Paraquat intoxication in Korea. Arch Environ Health. 2002 Mar-Apr;57(2):162-6.</citation>
    <PMID>12194161</PMID>
  </reference>
  <reference>
    <citation>Seok SJ, Gil HW, Jeong DS, Yang JO, Lee EY, Hong SY. Paraquat intoxication in subjects who attempt suicide: why they chose paraquat. Korean J Intern Med. 2009 Sep;24(3):247-51. doi: 10.3904/kjim.2009.24.3.247. Epub 2009 Aug 26.</citation>
    <PMID>19721862</PMID>
  </reference>
  <reference>
    <citation>Bismuth C, Garnier R, Baud FJ, Muszynski J, Keyes C. Paraquat poisoning. An overview of the current status. Drug Saf. 1990 Jul-Aug;5(4):243-51. Review.</citation>
    <PMID>2198050</PMID>
  </reference>
  <reference>
    <citation>Kim SJ, Gil HW, Yang JO, Lee EY, Hong SY. The clinical features of acute kidney injury in patients with acute paraquat intoxication. Nephrol Dial Transplant. 2009 Apr;24(4):1226-32. doi: 10.1093/ndt/gfn615. Epub 2008 Nov 5.</citation>
    <PMID>18987262</PMID>
  </reference>
  <reference>
    <citation>Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol. 2008;38(1):13-71. Review.</citation>
    <PMID>18161502</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 17, 2019</study_first_submitted>
  <study_first_submitted_qc>October 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>October 19, 2019</last_update_submitted>
  <last_update_submitted_qc>October 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Euthyrox</keyword>
  <keyword>Paraquat Intoxication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

